Form D/A — Adze Biotechnology Inc
0001787508-26-000001 · filed Nov 16, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(c)
- Reported offering amount
- $11,753,969
- Reported amount sold
- $9,253,969
- Minimum investment
- $25,000
- Investors
- 28
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Adze Biotechnology Inc
- CIK
- 1787508
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2332 GALIANO STREET, 2ND FL
CORAL GABLES, Florida 33134 - Phone
- 9177439401
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sidney Hopps · Executive OfficerMiami, Florida Find on LinkedIn ↗
-
G. Patrick Sage, II · DirectorKalamazoo, Michigan Find on LinkedIn ↗
-
Gabriel Raviv · DirectorGlenview, Illinois Find on LinkedIn ↗
-
Brendan Kenny · DirectorEdmonton, Alberta, Canada Find on LinkedIn ↗
-
Andrew Kinsella · Executive OfficerEdmonton, Alberta, Canada Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗